|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Trade accounts receivable, net | ||||||||||||||||||||
| Receivable from affiliate | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Current assets of discontinued operations held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Total property and equipment | ||||||||||||||||||||
| Less accumulated depreciation | ||||||||||||||||||||
| Finite lived intangible assets, net | ||||||||||||||||||||
| Customer relationship intangible assets | ||||||||||||||||||||
| Technology-Based Intangible Assets | ||||||||||||||||||||
| Non-compete and other agreements | ||||||||||||||||||||
| Total finite lived intangible assets, net | ||||||||||||||||||||
| Real estate, property and equipment, net | ||||||||||||||||||||
| Operating right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Equity method investments | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Long-term assets of discontinued operations held for sale | ||||||||||||||||||||
| Non-current assets held for sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, mezzanine equity and stockholders’ equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Payables to affiliates | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Capital lease obligations, current portion | ||||||||||||||||||||
| Finance lease obligations, current portion | ||||||||||||||||||||
| Operating lease obligations, current portion | ||||||||||||||||||||
| Notes payable, current maturities | ||||||||||||||||||||
| Accrued payroll and bonuses | ||||||||||||||||||||
| Asset-based lending credit agreement | ||||||||||||||||||||
| Asset retirement obligations, current portion | ||||||||||||||||||||
| Purchase option liability | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Current liabilities of discontinued operations held for sale | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Contingent payments for acquisitions | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Asset-based lending credit agreement | ||||||||||||||||||||
| Capital lease obligations, less current portion | ||||||||||||||||||||
| Finance lease obligations, less current portion | ||||||||||||||||||||
| Operating lease obligations, less current portion | ||||||||||||||||||||
| Notes payable, less current maturities | ||||||||||||||||||||
| Term loan - Related party | ||||||||||||||||||||
| Deferred gain and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Total preferred stock | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Retained losses | ||||||||||||||||||||
| Common Stock — $0.01 par value; 200,000,000 shares authorized, 3,379,605 shares issued and outstanding as of March 31, 2023 and December 31, 2022 | ||||||||||||||||||||
| Total common Stock — $0.01 par value; 200,000,000 shares authorized, 3,379,605 shares issued and outstanding as of March 31, 2023 and December 31, 2022 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Total additional paid-in capital | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities, mezzanine equity and stockholders’ equity | ||||||||||||||||||||
Loading...